Invention Application
- Patent Title: SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS
- Patent Title (中): 皮下注射人体长效因子Ⅸ
-
Application No.: PCT/EP2017/067127Application Date: 2017-07-07
-
Publication No.: WO2018007601A1Publication Date: 2018-01-11
- Inventor: VOIGT, Christine , PULI, Shilpa , ROBERTS, John , NOLTE, Marc
- Applicant: CSL BEHRING RECOMBINANT FACILITY AG
- Applicant Address: Wankdorfstrasse 10 3014 Bern CH
- Assignee: CSL BEHRING RECOMBINANT FACILITY AG
- Current Assignee: CSL BEHRING RECOMBINANT FACILITY AG
- Current Assignee Address: Wankdorfstrasse 10 3014 Bern CH
- Agency: HAUSER, Hans-Peter et al.
- Priority: US62/359745 20160708
- Main IPC: A61K38/48
- IPC: A61K38/48 ; A61K38/38 ; A61P7/04
Abstract:
The present invention relates to clinically relevant dosing regimens of prophylactic subcutaneously administered long-acting factor IX (i.e., human FIX fused to human albumin) in human patients.
Information query
IPC分类:
